A Single-Center Proof of Concept Pilot Study to Evaluate the Safety, Efficacy, and Tolerability of Sorafenib Combined With Therasphere in Subjects With Hepatocellular Carcinoma Awaiting Liver Transplantation.
Phase of Trial: Phase I
Latest Information Update: 23 Sep 2016
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Proof of concept; Therapeutic Use
- 13 Sep 2016 Status changed from active, no longer recruiting to completed.
- 22 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
- 14 Jul 2015 Planned End Date changed from 1 Jun 2016 to 1 Dec 2017 as reported by ClinicalTrials.gov record.